Trial intelligence / Profile preview

Ultrasound-guided PRP and sodium hyaluronate for partial-thickness rotator cuff tears

ChiCTR-IPR-17013172Phase 4Completed

Sponsor
Wuhan Fourth Hospital
Start
Jan 2014
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label trial of platelet-rich plasma and sodium hyaluronate in partial-thickness rotator cuff tear (PRCT) (4 arms), sponsored by Wuhan Fourth Hospital. Primary endpoint: American Shoulder and Elbow Surgeons score. Started Jan 2014; status: completed.

02

Drugs

platelet-rich plasmasodium hyaluronate
03

Conditions

partial-thickness rotator cuff tear (PRCT)

Beyond the preview

Go deeper on ChiCTR-IPR-17013172.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-17013172.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call